BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21777881)

  • 1. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve.
    Mussardo M; Latib A; Chieffo A; Godino C; Ielasi A; Cioni M; Takagi K; Davidavicius G; Montorfano M; Maisano F; Carlino M; Franco A; Covello RD; Spagnolo P; Grimaldi A; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2011 Jul; 4(7):743-50. PubMed ID: 21777881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses.
    Eltchaninoff H; Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A
    Arch Cardiovasc Dis; 2012 Mar; 105(3):132-40. PubMed ID: 22520795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration).
    Chieffo A; Buchanan GL; Van Mieghem NM; Tchetche D; Dumonteil N; Latib A; van der Boon RM; Vahdat O; Marcheix B; Farah B; Serruys PW; Fajadet J; Carrié D; de Jaegere PP; Colombo A
    J Am Coll Cardiol; 2013 Feb; 61(8):830-6. PubMed ID: 23333140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
    Godino C; Maisano F; Montorfano M; Latib A; Chieffo A; Michev I; Al-Lamee R; Bande M; Mussardo M; Arioli F; Ielasi A; Cioni M; Taramasso M; Arendar I; Grimaldi A; Spagnolo P; Zangrillo A; La Canna G; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1110-21. PubMed ID: 21087745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
    Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
    JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.
    Husser O; Pellegrini C; Kessler T; Burgdorf C; Thaller H; Mayr NP; Ott I; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1809-16. PubMed ID: 26718512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter valve-in-valve implantation with the Edwards SAPIEN in patients with bioprosthetic heart valve failure: the Milan experience.
    Latib A; Ielasi A; Montorfano M; Maisano F; Chieffo A; Cioni M; Mussardo M; Bertoldi L; Shannon J; Sacco F; Covello RD; Figini F; Godino C; Grimaldi A; Spagnolo P; Alfieri O; Colombo A
    EuroIntervention; 2012 Mar; 7(11):1275-84. PubMed ID: 22278193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter aortic valve implantation with the new balloon-expandable Sapien 3 versus Sapien XT valve system: a propensity score-matched single-center comparison.
    Nijhoff F; Abawi M; Agostoni P; Ramjankhan FZ; Doevendans PA; Stella PR
    Circ Cardiovasc Interv; 2015 Jun; 8(6):e002408. PubMed ID: 26033967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
    Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
    Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
    JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience.
    Abdel-Wahab M; Comberg T; Büttner HJ; El-Mawardy M; Chatani K; Gick M; Geist V; Richardt G; Neumann FJ;
    JACC Cardiovasc Interv; 2014 Mar; 7(3):284-92. PubMed ID: 24650401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
    Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
    Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commercial versus PARTNER study experience with the transfemoral Edwards SAPIEN valve for inoperable patients with severe aortic stenosis.
    Pendyala LK; Minha S; Barbash IM; Torguson R; Magalhaes MA; Okubagzi P; Loh JP; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jan; 113(2):342-7. PubMed ID: 24220281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
    Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes.
    Osten MD; Feindel C; Greutmann M; Chamberlain K; Meineri M; Rubin B; Mezody M; Ivanov J; Butany J; Horlick EM
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):475-85. PubMed ID: 19937781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis.
    Babaliaros V; Devireddy C; Lerakis S; Leonardi R; Iturra SA; Mavromatis K; Leshnower BG; Guyton RA; Kanitkar M; Keegan P; Simone A; Stewart JP; Ghasemzadeh N; Block P; Thourani VH
    JACC Cardiovasc Interv; 2014 Aug; 7(8):898-904. PubMed ID: 25086843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis.
    Borz B; Durand E; Godin M; Tron C; Canville A; Litzler PY; Bessou JP; Cribier A; Eltchaninoff H
    Heart; 2013 Jun; 99(12):860-5. PubMed ID: 23236027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.